PROYECTOS I+D
Projet ECO2016-78685-R MEPRIC
LA MEDICINA PERSONALIZADA Y LOS CONTRATOS DE RIESGO COMPARTIDO COMO NUEVOS PARADIGMAS DE LA GESTIÓN SANITARIA: MODELOS ECONÓMICOS TEÓRICOS Y APLICACIONES
date_range
Durée de 30 décembre 2016 à 29 décembre 2019
(36 mois)
euro
13 310,00 EUR
Sphère National.
Chercheurs
Publications liées au projet
Montrer par annualitéRévision
Article
-
Pre-approval incentives to promote adoption of personalized medicine: A theoretical approach
2019
Health Economics Review
-
Personalized medicine and pay-for-performance: should pharmaceutical firms be fully penalized when treatment fails?
2018
PharmacoEconomics
-
EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?
2017
European Journal of Health Economics
-
Endogenous versus exogenous generic reference pricing for pharmaceuticals
2017
International Journal of Health Economics and Management